In Quezon City, the company replaced old pipes at DMA Rosalia with 409 linear meters of 75-millimeter (mm) to 100-mm newer and more resilient ones to further improve water service to Barangay ...

Vancouver city council has voted to investigate the prospect of installing water meters on all of the city’s homes. Vancouver currently meters water usage in apartment buildings, and requires ...

Water meter (credit: ARAD GROUP, official site) The smart meter revolution is part of the broader smart city revolution that Arad is advancing nationwide. In recent years, the company has been ...

UK households with old 1980s electricity meters face losing their heating and hot water as a service is axed this year. Energy regulator Ofgem and trade association Energy UK are urging households ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel investigational covalent inhibitor of interleukin-2 ...

Aclaris Therapeutics stock opened at $2.39 on Friday. The stock has a market capitalization of $170.72 million, a PE ratio of -4.60 and a beta of 0.50. The business has a 50 day simple moving ...

The high end of this projection's range is 90 centimeters higher than the latest United Nations' global projection of 0.6 to 1.0 meters. Current sea-level projections rely on a range of methods to ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. The company’s lead asset, ATI-045, shows promising phase 2a results in atopic ...

WAYNE, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno ...

Aclaris reports potential of ATI-2138 as a dual inhibitor for inflammatory diseases, with promising preclinical and clinical trial results. Aclaris Therapeutics, Inc. has announced the publication ...

Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, MarketBeat reports.